
Peter Cicala
Peter Cicala's professional expertise focuses on all aspects of pharmaceutical and biotechnology intellectual property and strategic lifecycle management... | United States
*50 free lookup(s) per month.
No credit card required.
Peter Cicala’s Emails pc****@sh****.com
Peter Cicala’s Phone Numbers No phone number available.
Social Media
Peter Cicala’s Location United States
Peter Cicala’s Expertise Peter Cicala's professional expertise focuses on all aspects of pharmaceutical and biotechnology intellectual property and strategic lifecycle management of proprietary technology and products. His most recent experience involves advising start-up and venture-backed biotechnology companies through all aspects of drug development and the protection of proprietary technologies including long-range strategic planning and commercialization of therapeutics to maximize exclusivity. He has extensive experience in patent litigation, prosecution, product lifecycle management, R&D collaborations, M&A transactions and joint ventures in the pharma/biotech industry including small molecule, antibody and CAR-T products. Mr. Cicala has particular expertise with Hatch-Waxman Paragraph IV litigation as well as substantial experience with patent and regulatory litigation in Europe. Additionally, Mr. Cicala has over ten years of experience as a medicinal chemist and has worked on drug development programs for several major pharmaceutical companies and universities. Specialties: Primary areas of practice: patent portfolio life-cycle management, M&A transactional work, contract negotiation, and Hatch-Waxman patent litigation. In addition, FDA/EMEA regulatory advice, particularly in the area of data exclusivity in the US and EU. Technical training is in medicinal chemistry with many years of industrial organic synthesis experience specifically with Steroids and Beta-lactam antibiotics. Particular process development expertise in large-scale crystallization and chromatography, nano particles, pegylation, and polymers.
Peter Cicala’s Current Industry Undisclosed Biotech
Peter
Cicala’s Prior Industry
Merck
|
Lerner David Littenberg Krumholz And Mentlik
|
Enzon Pharmaceuticals
|
Mayne Pharma
|
Shire Pharmaceuticals
|
Celgene
|
Pretzel Therapeutics
|
Intercept Pharmaceuticals
|
Undisclosed Biotech
Not the Peter Cicala you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

Undisclosed Biotech
General Counsel and Head of IP and Innovation
Fri Jan 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Intercept Pharmaceuticals
Chief Patent Counsel
Sat Feb 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Apr 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Pretzel Therapeutics
Co-Founder
Fri Nov 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Celgene
Chief Patent Counsel
Sat Mar 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Nov 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Shire Pharmaceuticals
Vice President of Intellectual Property
Sat Jan 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Jan 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Mayne Pharma
Director, Intellectual property
Thu Jan 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Jan 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Enzon Pharmaceuticals
Associate General Counsel
Sat Jan 01 2000 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Jan 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Lerner David Littenberg Krumholz And Mentlik
Associate IP Attorney
Sun Nov 01 1998 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Jun 01 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Merck
Licensing Associate
Mon Jan 01 1996 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Jan 01 1998 00:00:00 GMT+0000 (Coordinated Universal Time)
Merck
Medicinal Chemist
Fri Nov 01 1991 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Jan 01 1996 00:00:00 GMT+0000 (Coordinated Universal Time)